FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Cash Flow 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | 29.1M | -30.1M | -232.9M | -241.5M | -90.4M | -73.9M |
| Depreciation & Amort. | 748,000 | 2.7M | 9.9M | 10.6M | 14.8M | 22.0M |
| Investing Activities | ||||||
| Capital Expenditure | -38,000 | 780,000 | -2.5M | -3.7M | -5.2M | -4.0M |
| Free Cash Flow | -4.8M | -138.3M | -317.5M | -184.7M | -112.4M | 77.6M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
FibroGen, Inc. Cash Flow — FAQ
FibroGen, Inc. (KYNB) cash flow over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's cash flow history?
The chart and table above show FibroGen, Inc.'s cash flow by year and by quarter, including the growth rate.